Why the study?
Does water restriction improve serum sodium in a patient with small cell lung cancer and hyponatremia not due to inappropriate ADH secretion?
Does water restriction improve serum sodium in a patient with small cell lung cancer and hyponatremia not due to inappropriate ADH secretion?
Hyponatremia in small cell lung cancer may be driven by an antidiuretic substance distinct from AVP and hypersecretion of ANP.
Answers are grounded in this paper and cite their sources.
Water restriction may raise sodium in SCLC hyponatremia not due to AVP; single case leaves open ANP role and needs prospective confirmation.
A 62-year-old man with small cell carcinoma (oat cell type) of the lung who had hyponatremia and renal sodium loss with inappropriate antidiuresis is reported. Plasma levels of arginine vasopressin (AVP) were not elevated inappropriately. Plasma levels of atrial natriuretic peptide (ANP), however, were high, and increased after water loading and hypertonic saline infusion. The renin-aldosterone axis was normal, as were adrenal, thyroid, and renal functions. Water restriction to 500 to 700 ml/d resulted in a rise in serum sodium. Analysis of the tumor tissue failed to demonstrate the presence of AVP or ANP. The findings (1) suggest that hyponatremia and renal sodium loss with inappropriate antidiuresis observed in the patient is due to an antidiuretic substance distinct from AVP, and (2) point to the possibility that hypersecretion of ANP may play a role in the pathophysiology.
No takes yet. Share an insight, caveat, or question.
Kamoi et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: